Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus (131)Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin Lymphoma: SWOG S0016

PURPOSE: Advanced follicular lymphomas (FL) are considered incurable with conventional chemotherapy and there is no consensus on the best treatment approach. Southwest Oncology Group (SWOG) and Cancer and Leukemia Group B compared the safety and efficacy of two immunochemotherapy regimens for FL in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Press, Oliver W., Unger, Joseph M., Rimsza, Lisa M., Friedberg, Jonathan W., LeBlanc, Michael, Czuczman, Myron S., Kaminski, Mark, Braziel, Rita M., Spier, Catherine, Gopal, Ajay K., Maloney, David G., Cheson, Bruce D., Dakhil, Shaker R., Miller, Thomas P., Fisher, Richard I.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2013
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3732010/
https://ncbi.nlm.nih.gov/pubmed/23233710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2012.42.4101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados